Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis
Abstract
Prolactin increase is a common side effect in antipsychotic treatment of schizophrenia, which crucially impacts drug choice and treatment compliance. As previous reviews by our group on this topic have included only few Chinese studies, we aimed to compare and rank antipsychotics based on broader evidence. This systematic review pooled data of 92 included studies from previous systematic review by Huhn et al. and 38 newly-added studies from Chinese-database search, including Chinese databases of China National Knowledge Infrastructure (CNKI), WANFANG DATA, WEIPU Journal Net (VIP) and Sino Biomedicine Service System (SinoMed) up to 20 May 2020. We conducted both network meta-analysis (NMA) and pairwise meta-analysis. The primary outcome was prolactin increase (continuous data). We calculated mean differences (MDs) for prolactin level with 95% confidence intervals (CIs) using random-effects model as primary analysis. 130 RCTs with 25,610 participants were included. Newer antipsychotics (risperidone, amisulpride and paliperidone) and older antipsychotics (chlorpromazine, haloperidol and sulpride) increase prolactin levels with large effect sizes. The SMD results were not identical to the MD results because consistency and heterogeneity assumption was tested to be different in calculations. Sensitivity analyses removing two studies with massive baseline imbalance or removing Chinese studies with high risk of bias did not affect the result. In contrast to a previous review clozapine and zotepine were no longer associated with decreased prolactin levels compared to placebo. Risperidone's ranking has more implications supported by CINeMA. This NMA draws the conclusion with larger sample size and extends evidence to more literature in this field.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · see citing works
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269 · see citing works
Cochrane Handbook for Systematic Reviews of Interventions
Tarsilla, M. (2010) · Journal of MultiDisciplinary Evaluation · doi:10.56645/jmde.v6i14.284 · Cited by 5,228 · see citing works
Graphical tools for network meta-analysis in STATA
Chaimani, A., Higgins, J. P. T., Mavridis, D., Spyridonos, P., & Salanti, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076654 · Cited by 2,473 · see citing works
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
Higgins, J. P. T., Jackson, D., Barrett, J. K., Lu, G., Ades, A. E., & White, I. R. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1044 · Cited by 2,098 · see citing works
CINeMA: an approach for assessing confidence in the results of a network meta-analysis
Nikolakopoulou, A., Higgins, J. P. T., Papakonstantinou, T., Chaimani, A., Del Giovane, C., Egger, M., & Salanti, G. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003082 · Cited by 1,935 · see citing works
Huhn, M., Nikolakopoulou, A., Schneider-Thoma, J., Krause, M., Samara, M., Peter, N., Arndt, T., Bäckers, L., Rothe, P., Cipriani, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31135-3 · Cited by 1,753 · see citing works
Imputing missing standard deviations in meta-analyses can provide accurate results
Furukawa, T. A., Barbui, C., Cipriani, A., Brambilla, P., & Watanabe, N. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.06.006 · Cited by 1,568 · see citing works
Evaluating the quality of evidence from a network meta-analysis
Salanti, G., Del Giovane, C., Chaimani, A., Caldwell, D. M., & Higgins, J. P. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099682 · Cited by 1,402 · see citing works
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Buchanan, R. W., Kreyenbuhl, J. A., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., Himelhoch, S. S., Fang, B., Peterson, E. L., Aquino, P. R., et al. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp116 · Cited by 901 · see citing works
Rhodes, K. M., Turner, R., & Higgins, J. P. T. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.08.012 · Cited by 398 · see citing works
Kinon, B. J., Gilmore, J. A., Liu, H., & Halbreich, U. M. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00127-0 · Cited by 350 · see citing works
Peuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0157-3 · Cited by 350 · see citing works
Chlorpromazine versus placebo for schizophrenia
Adams, C. E., Awad, G. A., Rathbone, J., & Thornley, B. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000284.pub2 · Cited by 241 · see citing works
Kinon, B. J., Chen, L., Ascher‐Svanum, H., Stauffer, V. L., Kollack‐Walker, S., Zhou, W., Kapur, S., & Kane, J. M. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.164 · Cited by 180 · see citing works
Chlorpromazine versus placebo for schizophrenia
Adams, C. E., Awad, G. A., Rathbone, J., Thornley, B., & Soares‐Weiser, K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000284.pub3 · Cited by 167 · see citing works
Kishimoto, T., Hagi, K., Nitta, M., Kane, J. M., & Correll, C. U. (2019) · World Psychiatry · doi:10.1002/wps.20632 · Cited by 131 · see citing works
Prevalence of Hyperprolactinemia in Schizophrenia
Montgomery, J., Winterbottom, E., Jessani, M., Kohegyi, E., Fulmer, J., Seamonds, B., & Josiassen, R. C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1108 · Cited by 130 · see citing works
Side effect burden of antipsychotic drugs in real life – Impact of gender and polypharmacy
Iversen, T., Steen, N. E., Dieset, I., Hope, S., Mørch, R. H., Gardsjord, E. S., Jørgensen, K. N., Melle, I. S., Andreassen, O. A., Molden, E., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.004 · Cited by 120 · see citing works
Classics in Chemical Neuroscience: Risperidone
Chopko, T. C., & Lindsley, C. W. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00159 · Cited by 105 · see citing works
Oosthuizen, P. P., Emsley, R. A., Turner, H. J., & Keyter, N. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004262 · Cited by 67 · see citing works
Durgam, S., Greenberg, W. M., Li, D., Lu, K., Laszlovszky, I., Németh, G., Migliore, R., & Volk, S. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4450-3 · Cited by 64 · see citing works
Prescribers fear as a major side‐effect of clozapine
Cohen, D. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12294 · Cited by 53 · see citing works
Content and Quality of 10 000 Controlled Trials in Schizophrenia Over 60 Years
Miyar, J., & Adams, C. E. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr140 · Cited by 47 · see citing works
Migliardi, G., Spina, E., D’Arrigo, C., Gagliano, A., Germanò, E., Siracusano, R., DÍAZ, F. J., & de León, J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.009 · Cited by 45 · see citing works
Stahl, S. M., Sy, S., & Maguire, G. A. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13266 · Cited by 43 · see citing works
The Effect of Long-Term Antipsychotic Treatment on Prolactin
Staller, J. A. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.317 · Cited by 41 · see citing works
Llorca, P., Lançon, C., Hartry, A., Brown, T. M., DiBenedetti, D. B., Kamat, S., & François, C. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1213-6 · Cited by 24 · see citing works
Glatard, A., Guidi, M., Delacrétaz, A., Dubath, C., Grosu, C., Laaboub, N., von Gunten, A., Conus, P., Csajka, C., & Eap, C. B. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00821-w · Cited by 17 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Petersenn, S., Fleseriu, M., Casanueva, F. F., Giustina, A., Biermasz, N., Biller, B. M. K., Bronstein, M., Chanson, P., Fukuoka, H., Gadelha, M., et al. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00886-5 · Cited by 411 · see citing works
Pillinger, T., Howes, O. D., Correll, C. U., Leucht, S., Huhn, M., Schneider‐Thoma, J., Gaughran, F., Jauhar, S., McGuire, P. K., Taylor, D. M., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00262-6 · Cited by 149 · see citing works
Correll, C. U., Angelov, A. S., Miller, A., Weiden, P. J., & Brannan, S. K. (2022) · Schizophrenia · doi:10.1038/s41537-022-00320-1 · Cited by 72 · see citing works
The Involvement of Prolactin in Stress-Related Disorders
Faron‐Górecka, A., Latocha, K., Pabian, P., Kolasa, M., Sobczyk-Krupiarz, I., & Dziedzicka‐Wasylewska, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043257 · Cited by 53 · see citing works
Fabiano, N., Wong, S., Zhou, C., Correll, C. U., Højlund, M., & Solmi, M. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.11.013 · Cited by 47 · see citing works
Wang, D., Schneider-Thoma, J., Siafis, S., Qin, M., Wu, H., Zhu, Y., Davis, J. M., Priller, J., & Leucht, S. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.03.003 · Cited by 44 · see citing works
“As observed in prior studies (Huhn et al., 2019; Lu et al., 2022; Zhu et al., 2021), both ari-piprazole LAI and oral formulations were associated with a reduction in prolactin levels when compared to placebo.”
ResultCrosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Goh, K. K., Chen, C. Y.-A., Wu, T., Chen, C.-H., & Lu, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137092 · Cited by 37 · see citing works
Halstead, S., Yap, C. X., Warren, N., Agarwal, S. M., Brand, B. A., Chan, S. K. W., Cipriani, A., Correll, C. U., Crossley, N. A., D’Ambrosio, E., et al. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00162-2 · Cited by 38 · see citing works
Estrogen and psychosis — a review and future directions
Mu, E., Gurvich, C., & Kulkarni, J. (2024) · Archives of Women s Mental Health · doi:10.1007/s00737-023-01409-x · Cited by 31 · see citing works
Koch, M. T., Carlson, H. E., Kazimi, M. M., & Correll, C. U. (2023) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2023.03.007 · Cited by 31 · see citing works
Manta, A., Georganta, A., Roumpou, A., Zoumpourlis, V., Spandidos, D. A., Rizos, E. N., & Peppa, Μ. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13479 · Cited by 38 · see citing works
Solmi, M., Lähteenvuo, M., Tanskanen, A. J., Corbeil, O., Mittendorfer‐Rutz, E., Correll, C. U., Tiihonen, J., & Taipale, H. T. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae058 · Cited by 28 · see citing works
Antipsychotic-Related Prolactin Changes: A Systematic Review and Dose–Response Meta-analysis
Lin, X. J., Siafis, S., Tian, J., Wu, H., Qin, M., Correll, C. U., Schneider‐Thoma, J., & Leucht, S. (2025) · CNS Drugs · doi:10.1007/s40263-025-01218-z · Cited by 27 · see citing works
UTILIZAÇÃO DE PRÓPOLIS OU MEL NO TRATAMENTO DE FERIDAS LIMPAS INDUZIDAS EM RATOS
Rahal, S. C., Bracarense, A. P. F. R. L., TANAKA, C. Y., GRILLO, T. P., & LEITE, C. A. L. (2003) · Archives of Veterinary Science · doi:10.5380/avs.v8i1.4018 · Cited by 21 · see citing works
Solmi, M., Lähteenvuo, M., Correll, C. U., Tanskanen, A. J., Tiihonen, J., & Taipale, H. T. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac152 · Cited by 20 · see citing works
Burghardt, K. J., Mando, W., Seyoum, B., Yi, Z., & Burghardt, P. R. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2689 · Cited by 16 · see citing works
Aymerich, C., Pedruzo, B., Pacho, M., Laborda, M., Herrero, J., Pillinger, T., McCutcheon, R. A., Alconada, D. A., Bordenave, M., Martínez-Querol, M., et al. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106049 · Cited by 15 · see citing works
Hypothalamic Subunit Volumes in Schizophrenia and Bipolar Spectrum Disorders
Ruggeri, A., Nerland, S., Mørch-Johnsen, L. E., Jørgensen, K. N., Barth, C., Wortinger, L. A., Andreou, D., Andreassen, O. A., & Agartz, I. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad176 · Cited by 15 · see citing works
Kane, J. M., Eshet, R., Harary, E., Tohami, O., Elgart, A., Knebel, H., Sharon, N. A., Suett, M., Franzenburg, K. R., Davis, G. L., et al. (2024) · CNS Drugs · doi:10.1007/s40263-024-01102-2 · Cited by 14 · see citing works
Andrade, C. (2023) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23f14790 · Cited by 14 · see citing works
How to classify antipsychotics: time to ditch dichotomies?
McCutcheon, R. A., Cannon, A., Parmer, S., & Howes, O. D. (2023) · The British Journal of Psychiatry · doi:10.1192/bjp.2023.131 · Cited by 12 · see citing works
Clozapine After 1 Failed Antipsychotic Drug Trial in First-Episode Psychosis
Li, X., Lu, C., Zhai, Z., Smith, R. C., Zhang, S., Wang, H., Wang, C., Yao, Z., Chen, Z., Xu, X., et al. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2026.0086 · Cited by 11 · see citing works
Mao, J., Fan, K., Zhang, Y., Wen, N., Fang, X., Ye, X., & Chen, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19912 · Cited by 9 · see citing works
Cao, Y.-L., -Zhu, L., Zhang, H., Meng, J.-H., Wu, H.-J., Wang, X., Wu, J.-H., Zou, J., Fang, M., An, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.888522 · Cited by 8 · see citing works
Do antipsychotics work in people with schizophrenia? A review of outcomes and effect sizes
Correll, C. U. (2025) · CNS Spectrums · doi:10.1017/s1092852925100461 · Cited by 7 · see citing works
Aymerich, C., Pedruzo, B., de Pablo, G. S., Labad, J., McCutcheon, R. A., Pillinger, T., Torres, M. Á. G., Sánchez‐Gistau, V., Oliver, D., Alconada, D. A., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.009 · Cited by 6 · see citing works
Hynes-Ryan, C., Keating, D., Carolan, A., Brand, B. A., Dazzan, P., Gaughran, F., Hahn, M., Halstead, S., Harrington, S. M., Hartnett, Y., et al. (2026) · Schizophrenia Bulletin · doi:10.1093/schbul/sbag023 · Cited by 6 · see citing works
Mazo, G. E., & Yakovleva, Y. V. (2024) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2024-972 · Cited by 6 · see citing works
Peng, Q., Dai, Z., Yin, J., Lv, D., Luo, X., Xiong, S., Yang, Z., Chen, G., Wei, Y., Wang, Y., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1187111 · Cited by 5 · see citing works
Yao, K., Yang, L., Zhang, Q., Li, C., Tian, H., & Zhuo, C. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06818-z · Cited by 4 · see citing works
Dance/movement therapy for improving metabolic parameters in long-term veterans with schizophrenia
Zhou, Z., Guan, H., Xiu, M., & Wu, F. (2024) · Schizophrenia · doi:10.1038/s41537-024-00435-7 · Cited by 4 · see citing works
Pan, Y., Li, L., Xia, X., Li, Z., Dai, J., Wu, J., Liu, T., Chen, M., Ma, J., Liu, Y., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06629-2 · Cited by 4 · see citing works
Yang, J., Zhu, X., Wang, W., Wang, H., Gong, H., Zhang, Y., Correll, C. U., Xiao, L., & Wang, G. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.04.011 · Cited by 4 · see citing works
Liu, X., Sun, X., Li, L., Zeng, K., Li, Y., Gao, Y., & Ma, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1124691 · Cited by 4 · see citing works
Rosa, E. D., Arpaia, S., Michelina, S. V., Oliva, F., Medana, C., Calza, P., & Bello, F. D. (2025) · Journal of Separation Science · doi:10.1002/jssc.70299 · Cited by 3 · see citing works
Female sexual dysfunction as an adverse effect of drugs: a narrative review
Piha, M. O. W., Kero, K., & Tornio, A. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108623 · Cited by 3 · see citing works
Lobos, C. A., Marcelo Arancibia, M., Cortés-Jofré, M., Huang, T., Li, T., Eva Madrid, A., Bonfill, X., & Leucht, S. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116670 · Cited by 3 · see citing works
Antipsychotic-induced hyperprolactinemia: Toxicologic mechanism and the increased breast cancer risk
Bird, S. B. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101927 · Cited by 4 · see citing works
Zhang, L., Zheng, Y., Huang, J., Yu, W., Zhou, L., He, L., Li, Y., Hu, H., Li, G., Shen, Y., et al. (2025) · CNS Drugs · doi:10.1007/s40263-025-01216-1 · Cited by 2 · see citing works
Nicola, M. D., Pepe, M., Milintenda, M., Massetti, M., Moccia, L., Panaccione, I., & Sani, G. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15110502 · Cited by 2 · see citing works
Chronic hyperprolactinemia is associated with enhanced high‐fat diet binge eating in female mice
Cornejo, M. P., Lopez‐Vicchi, F., Winne, C. D., Pascual, F. L., Ornstein, A. M., Reynaldo, M. B., Perrello, M., & Becú‐Villalobos, D. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70123 · Cited by 2 · see citing works
El‐Gabry, D. A., Ahmed, H. F., Andrade, G., Reddy, M. S., Aziz, K. A., Alkharoossi, A., Alkaabi, A. A., Alketbi, J., Omara, A. E., Ahbabi, M. A. A., et al. (2026) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000619 · Cited by 2 · see citing works
More than a Half-Century with Haloperidol: Glories, Disparities, and Use Today
Mills, J. (2023) · Issues in Mental Health Nursing · doi:10.1080/01612840.2022.2158683 · Cited by 2 · see citing works
Wu, T., Goh, K. K., Chiu, Y.-H., Lin, C., Chen, C.-H., Lane, H., & Lu, M. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.02.052 · Cited by 2 · see citing works
Correll, C. U., Durgam, S., Kozauer, S. G., Lakkis, H. D., Chen, C., Vanover, K. E., Mates, S. L., & Davis, R. E. (2025) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000597 · Cited by 2 · see citing works
Zhang, H., Peng, J., & Wang, Y. (2023) · Psychiatric Quarterly · doi:10.1007/s11126-023-10025-y · Cited by 2 · see citing works
Hasni, D., Surya, B. E., Anissa, M., & Anggraini, D. (2023) · Bali Medical Journal · doi:10.15562/bmj.v12i1.4018 · Cited by 2 · see citing works
Moritz Jastrowitz (1839–1912): moria madness, spider glial cells and X-rays – Psychiatry in history
Dalvi, M. (2023) · The British Journal of Psychiatry · doi:10.1192/bjp.2023.135 · Cited by 1 · see citing works
Freitas, T. M., Carvalho, G. M. V., & Cavalcanti, G. C. P. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n5-141 · Cited by 1 · see citing works
Labad, J., Gálvez, V., Gregorio, M., Palacio, A., Manzano, Y., Gabernet, R., Borràs, M., Niubó, M., Silles, S., Toll, A., et al. (2025) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.sjpmh.2025.10.001 · Cited by 1 · see citing works
Lobos, C. A., Marcelo Arancibia, M., Cortés-Jofré, M., Huang, T., Li, T., Eva Madrid, A., & Leucht, S. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.116956 · Cited by 1 · see citing works
兰志敏, Guan, X., Xiu, M., & Pan, A. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02290-2 · Cited by 1 · see citing works
Zhang, L., Huang, J., Yu, W., He, S., Yu, Y., Gu, F., Tang, D., Wang, H., Zheng, Q., Shen, Y., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3988000
Antipsychotics for antipsychotic-naïve people with psychosis
Wu, H., Burschinski, A., Schneider‐Thoma, J., Leucht, S., & Siafis, S. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015665
Brand, B. A. (2024) · doi:10.33612/diss.1087705066
Stanley, T. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_28
Research Progress on Cognitive Impairment in Schizophrenia
张, 曦. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541030
Should we be Prescribing Fluphenazine Long-Acting Injectable Formulation?
Rowland, D. C. (2025) · Current Psychiatry Reports · doi:10.1007/s11920-025-01610-y
Chen, B., Ma, R., Zhang, S., & Liu, Y. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.06.009
Yang, J., Zhu, X., & Xiao, L. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.06.006
Antipsychotic medications in affective disorders
Vázquez, G. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33580-8.00009-x
Prolactin monitoring for patients on antipsychotic drugs: A narrative review of clinical relevance
Kar, N., & Cook, N. (2025) · Archives of Biological Psychiatry · doi:10.25259/abp_17_2025
Management of abnormal uterine bleeding in primary care
Horne, M., & Martin, K. (2025) · The Nurse Practitioner · doi:10.1097/01.npr.0000000000000362
Sangngarm, A., Werawattanachai, C., Somrak, K., Silaket, S., & Boonlue, T. (2025) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2025.2593315
Antipsychotic Medication Preferences: A Large-Scale Survey
Wezenberg, B. N., Bouws, J., van der Pluijm, M., de Koning, M. B., Kikkert, M., Blankers, M., Sommer, I. E., van Dijk, F. A., & de Haan, L. (2026) · Pharmacopsychiatry · doi:10.1055/a-2784-3444
Yalçın, Z. Ö., Bayraktar, İ., Kaşıkçı, M., Yalçın, N., Eroğlu, E. Ö., Yağcioğlu, A. E. A., & Gürel, Ş. C. (2026) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2026.107838
Li, Z., Wang, D., Men, T., Fu, Z., & Shen, Y. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s587771
Do Antipsychotics Work in People with Schizophrenia?
Correll, C. U. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009587747.008
Chen, C., Liu, Q., Su, X., & Li, W.-Q. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111974
- Authors
- Zhu, Y., Zhang, C., Siafis, S., Zhuo, K., Zhu, D., Wu, H., Liu, D., Jiang, K., Wang, J., Leucht, S., & Li, C.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Technical University of Munich (DE)
- Corresponding author
- Liu, Dengtang
- Leucht, Stefan
- Li, Chunbo
- ORCID
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 237
- Pages
- 20-25
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W3197949843
- Cited by
- 69
- References
- 29
- Citations by year
- 2026: 10 · 2025: 26 · 2024: 11 · 2023: 15 · 2022: 5 · 2021: 1
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Funders
- Shanghai Clinical Research Center for Mental Health (19MC1911100)
- School of Medicine, Shanghai Jiao Tong University
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- prolactin, antipsychotic drugs
- MeSH terms
- Network Meta-Analysis, Humans, Prolactin, Schizophrenia, Antipsychotic Agents, Risperidone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
